State Of Wyoming Gritstone Bio, Inc. Transaction History

State Of Wyoming

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$0.62 - $2.35 $937 - $3,553	1,512 New	1,512 $0
Q2 2022 Aug 15, 2022	BUY	$1.77 - $4.34 $4,648 - $11,396	2,626 Added 39.41%	9,289 $22,000
Q1 2022 May 13, 2022	SELL	$4.03 - $12.19 $1,914 - $5,790	-475 Reduced 6.65%	6,663 $27,000
Q4 2021 Feb 11, 2022	BUY	$8.76 - $13.71 $5,904 - $9,240	674 Added 10.43%	7,138 $92,000
Q3 2021 Feb 11, 2022	SELL	$6.41 - $13.54 $2,929 - $6,187	-457 Reduced 6.6%	6,464 $70,000
Q2 2021 Feb 11, 2022	BUY	$8.13 - $10.2 $56,267 - $70,594	6,921 New	6,921 $63,000

35.4M

395K

132K

Ticker GRTS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 73,006,896
Market Cap $2.19M
Description
Gritstone bio, Inc., a clinical-stage biotechnology company, engages in developing immunotherapies against multiple cancer types and infectious diseases. Its lead product candidate is GRANITE, a neoantigen-based immunotherapy for the treatment of solid tumors, including metastatic non-small cell lung cancer, as well as gastroesophageal, bladder ...

Get notified when there are updates to the investment portfolio of State Of Wyoming, based on Form 13F filings with the SEC.

Stay updated on State Of Wyoming with notifications on news.